Engineered Polymer Nanoparticles: A Potent Weapon Against Cancer [ 2009-01-01 - 2012-12-31 ]

Research Grant

Researchers: Nigel McMillan (Chief Investigator) ,  Professor Michael Monteiro (Chief Investigator) ,  Professor Michael Monteiro (Chief Investigator)

Brief description Engineered Polymer Nanoparticles: A Potent Weapon Against Cancer. Cervical cancer is the commonest cause of cancer death in women under the age of 50 worldwide, the 8th most common cancer among women in Australia, and is the leading cause of cancer death in Aboriginal women. While a vaccine is available to prevent HPV-mediated disease, it would not impact upon death rates for at least 25 years. The systemic delivery of RNAi offers to best opportunity to solve this problem. The delivery devices will be designed with precision and function to meet the delivery needs in vivo. These polymer structures will be suitable for use in drug and gene delivery providing Australian products with advanced features and capabilities, significantly improving product performance.

Funding Amount $400,000

Funding Scheme Discovery Projects

View this grant in the ARC Data Portal